Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Xtrana, Inc. (OTC BB:XTRN.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Insider
Recent Events
Aug 29Price hit new 52-week low ($0.42)
Location
590 Burbank Street, Suite 205
Broomfield, CO 80020
Phone: (303) 466-4424
Fax: (805) 654-0681
Email: invest@biopool.com
Employees (last reported count): 86
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 25%
·Over the last 6 months:
 · one insider buy; 3,000  shares
·Institutional: 0% (0% of float)
(0 institutions)
·Net Inst. Selling: 19.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Xtrana, Inc., formerly known as Biopool International, Inc., is engaged in the research, development, manufacture, and marketing of in vitro (outside the body) diagnostic and nucleic acid testing products. The Company sells over 100 in vitro diagnostic products on a worldwide basis to hospitals, clinical laboratories, commercial reference laboratories, and research institutions for use in disease detection and prevention. In addition, as a result of the merger it completed in August 2000 with Xtrana, Inc., the Company owns newly developed proprietary technology for the development of nucleic acid-based tests for use in drug discovery, detection of environmental and food contaminants, forensics and identity testing, human and animal diseases, genetic predisposition to disease, and other applications. Specific pathogens for which the Company is currently developing tests include E. coli, Listeria and Salmonella in food, Cryptosporidium and coliforms in water, and chlamydia.
More from Market Guide: Expanded Business Description

Financial Summary
Xtrana, Inc. is engaged in the research, development, manufacture and marketing of in vitro (outside the body) diagnostic products to hospitals, clinical and commercial laboratories, blood centers and research institutions. For the six months ended 6/01, sales fell 6% to $4.9 million. Net loss totaled $1.7 million vs. an income of $589 thousand. Results reflect lower European sales, lower profit margins, merger-related expenses and increased R and D spendings.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
Michael D. Bick, Chmn./Pres.
Timothy J. Dahltorp, CEO/CFO
Robert K. Foote, Secy.
Calyon H. Duke, VP.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:XTRN.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Aug-2001
$0.42 
Recent Price$0.49 
52-Week High
on 2-Oct-2000
$2.031
Beta0.54 
Daily Volume (3-month avg)7,500 
Daily Volume (10-day avg)13.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-66.6%
52-Week Change
relative to S&P500
-55.3%
Share-Related Items
Market Capitalization$8.41M
Shares Outstanding17.2M
Float12.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.89 
Earnings (ttm)-$0.20 
Earnings (mrq)-$0.04 
Sales (ttm)$0.59 
Cash (mrq)$0.14 
Valuation Ratios
Price/Book (mrq)0.55 
Price/EarningsN/A 
Price/Sales (ttm)0.82 
Income Statements
Sales (ttm)$9.52M
EBITDA (ttm)-$3.33M
Income available to common (ttm)-$3.33M
Profitability
Profit Margin (ttm)-34.9%
Operating Margin (ttm)-34.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-19.34%
Return on Equity (ttm)-21.33%
Financial Strength
Current Ratio (mrq)3.55 
Debt/Equity (mrq)0 
Total Cash (mrq)$2.43M
Short Interest
As of 10-May-1999
Shares Short0 
Shares Short
(Prior Month)
3,000 
Daily Volume18.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.